GlassScriptPhysician profile
Farhoud Khosravi
NPI 1285874362
$2,001.65
in general payments reported to CMS, 2019-2025
17 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $553 · 2020: $231 · 2021: $39.92 · 2022: $736 · 2023: $27.13 · 2024: $126 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $672.47 | 2019-2025 | Spyglass, Rotatable Snare, Overstitch Endoscopic Suturing System |
| Medtronic, INC. | $331.09 | 2022 | |
| Olympus America INC. | $307.22 | 2019-2025 | Visiglide, Evis Exera III Colonovideoscope, Single Use Biopsy Valve (Sterile) |
| Micro-Tech Endoscopy USA, INC. | $117.14 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $105.44 | 2019-2020 | |
| Gilead Sciences, INC. | $93.33 | 2020-2024 | |
| Abbvie INC. | $92.38 | 2019-2023 | |
| Endogastric Solutions, INC | $54.99 | 2019 | |
| Ironwood Pharmaceuticals, INC | $46.94 | 2019-2020 | |
| Celgene Corporation | $33.61 | 2022 | |
| Shionogi INC | $25.58 | 2019-2020 | |
| Lilly USA, LLC | $22.05 | 2025 | Omvoh |
| Ucb, INC. | $21.66 | 2019 | |
| Genzyme Corporation | $21.55 | 2022 | |
| Lucid Diagnostics INC. | $20.92 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.54 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farhoud Khosravi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.